BeOne MedicinesvsThermo Fisher Scientific

ONC and TMO stock compared: price, dividend, valuation and results, from SEC filings.

ONC

BeOne Medicines Ltd.

$390.94

Value $43.4B

-2.19%
ONC's page

TMO

Thermo Fisher Scientific Inc

$669.54

Value $249B

-2.79%
TMO's page

BeOne Medicines (ONC) has a market value of $43.4B and Thermo Fisher Scientific (TMO) $249B. Over the last year, with dividends, ONC moved +10.5% and TMO +17.1%. The P/E is 47.4 for ONC and 35.2 for TMO. Dividend yield: ONC none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ONC$43.4B

    TMO$249B

    TMO is 5.7 times ONC

  • Revenue, 12 months

    ONC$6.6B

    TMO$47.4B

    TMO is 7.2 times ONC

  • Net income, 12 months

    ONC$916M

    TMO$7.1B

    TMO is 7.7 times ONC

  • Operating margin

    ONC17.8%

    TMO17.9%

    0.1 points apart

  • ROIC

    ONC16.2%

    TMO8.2%

    8.0 points apart

  • P/E

    ONC47.4

    TMO35.2

    ONC is 1.3 times TMO

  • Dividend yield

    ONC0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    ONC+7.2%

    TMO+6.8%

    0.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ONC+7.2%

TMO+6.8%

507510020222023202420252026
Returns by period
PeriodONCWith dividendsTMOWith dividends
1 year since November 19, 2025+10.5%Price +10.5%+17.1%Price +16.7%
3 years since November 20, 2023+108.1%+27.7% a yearPrice +108.1%+44.1%+13.0% a yearPrice +42.7%
5 years since November 19, 2021+7.2%+1.4% a yearPrice +7.2%+6.8%+1.3% a yearPrice +5.3%
10 years since November 21, 2016+1,140.7%+28.6% a yearPrice +1,140.7%+371.2%+16.8% a yearPrice +358.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ONCBeOne MedicinesTMOThermo Fisher Scientific

Valuation

ONCTMO
Valuation
Price$390.94$669.54
Market value$43.4B$249B
Enterprise value (EV)–$284B
P/E47.435.2
P/E, 5-year median–32.7
P/B7.54.5
EV/EBIT–33.5
Free cash flow yield3.3%3.1%

Results and growth

ONCTMO
Results and growth
Revenue, 12 months$6.6B$47.4B
Net income, 12 months$916M$7.1B
Free cash flow, 12 months$1.4B$7.6B
Earnings per share, 12 months$7.80$18.96
Revenue growth, year on year40.2%3.9%
Revenue growth a year, past+76.9%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

ONCTMO
Margins and returns on capital
Gross margin89.4%–
Operating margin17.8%17.9%
Net margin13.9%14.9%
ROIC16.2%8.2%
ROE18.9%13.4%

Balance sheet

ONCTMO
Balance sheet
Cash$5.8B$6.1B
Total debt–$41.4B
Net debt / EBITDA–3.7
Interest cover8.3×5.5×

Dividends and buybacks

ONCTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ONC or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, BeOne Medicines or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($249B) is about 5.7 times BeOne Medicines ($43.4B), at today's prices.

How did ONC and TMO stock do over the last 10 years?

Since November 21, 2016, ONC's price moved +1,140.7% and TMO's +358.1%. With dividends: ONC +1,140.7% (+28.6% a year), TMO +371.2% (+16.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, ONC or TMO?

The dividend yield at today's price is none for BeOne Medicines and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of ONC and TMO?

At today's price, the P/E is 47.4 for ONC and 35.2 for TMO. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, BeOne Medicines or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 13.9% for BeOne Medicines and 14.9% for Thermo Fisher Scientific, and the operating margin 17.8% and 17.9%. Revenue was $6.6B and $47.4B.

Which is the better investment, BeOne Medicines or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.